Crossmark

Dual Antiplatelet Therapy Beyond 1 Year Postinfarction: The Time Has Come and We’re Beginning to Know Who Will Benefit

Crossref DOI link: https://doi.org/10.1016/j.rec.2016.01.020

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz-Nodar, Juan M.
License Information

Text and Data Mining valid from 2016-05-01
More Information

This article is maintained by: Elsevier

Article Title: Dual Antiplatelet Therapy Beyond 1 Year Postinfarction: The Time Has Come and We’re Beginning to Know Who Will Benefit

Journal Title: Revista Española de Cardiología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rec.2016.01.020

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.recesp.2016.01.021

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rec.2015.12.022

Content Type: article

Copyright: © 2016 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.